tiprankstipranks
Petros Pharmaceuticals (PTPI)
OTHER OTC:PTPI
US Market

Petros Pharmaceuticals (PTPI) Financial Statements

201 Followers

Petros Pharmaceuticals Financial Overview

Petros Pharmaceuticals's market cap is currently $224.57K. The company's EPS TTM is $; its P/E ratio is -0.27; Petros Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Mar 22Dec 20
Income Statement
Total Revenue$ 5.11M$ 5.82M$ 5.99M$ 7.81M$ 9.56M
Gross Profit$ 3.90M$ 4.19M$ 3.70M$ 6.21M$ 5.51M
Operating Income$ -17.68M$ -13.62M$ -19.92M$ -18.05M$ -17.28M
EBITDA$ -10.81M$ -4.21M$ -13.73M$ -1.74M$ -12.21M
Net Income$ -14.32M$ -8.16M$ -20.04M$ -8.99M$ -20.59M
Balance Sheet
Cash & Short-Term Investments$ 3.71M$ 13.34M$ 9.43M$ 23.85M$ 17.14M
Total Assets$ 10.64M$ 33.80M$ 32.42M$ 67.39M$ 69.85M
Total Debt$ 7.39M$ 8.28M$ 9.88M$ 405.02K$ 7.81M
Net Debt$ 3.68M$ -5.06M$ 456.53K$ -23.44M$ -9.33M
Total Liabilities$ 18.10M$ 21.32M$ 15.72M$ 31.85M$ 52.38M
Stockholders' Equity$ -7.47M$ 12.48M$ 16.70M$ 35.54M$ 17.47M
Cash Flow
Free Cash Flow$ -2.63M$ -7.63M$ -12.80M$ -11.86M$ -15.31M
Operating Cash Flow$ -2.60M$ -7.63M$ -12.80M$ -11.86M$ -15.31M
Investing Cash Flow$ -24.59K$ 0.00$ 0.00$ 0.00$ -4.63K
Financing Cash Flow$ -7.00M$ 11.54M$ -1.62M$ 18.57M$ 30.30M
Currency in USD

Petros Pharmaceuticals Earnings and Revenue History

Petros Pharmaceuticals Debt to Assets

Petros Pharmaceuticals Cash Flow

Petros Pharmaceuticals Forecast EPS vs Actual EPS